Systemic sclerosis (SSc; scleroderma) is a disease in which inflammatory and fibrotic changes result in overproduction and accumulation of collagen and other extracellular matrix proteins, resulting in intimal vascular damage, fibrosis, and occasionally organ dysfunction affecting the gastrointestinal, lung, heart, and renal systems. There are two classifications of SSc—limited cutaneous or CREST (calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, and telangectasias) syndrome, where skin thickening occurs mainly in the distal extremities and facial/neck areas and internal organ involvement, if present, occurs later in the disease process; and diffuse cutaneous disease where there is a more rapid progression of skin thickening from distal to proximal and organ involvement can be severe and occur early in the disease. As noted by various authors, there is no “crystal ball” into which one can look to see the outcome of the disease, and involvement varies significantly from one person to the next.
Search results for: heart disease
Rheum with a View
Panush’s perspectives on selections from the literature
Thoughts after a Broken Ankle
A forced convalescence leads to insights into rheumatology and medicine
Rheum Around the World
ACR Members Help Educate Rheumatologists Around the World
ICD-10 from a Coder’s Perspective
For the past 30 years, coders have used the International Classification of Diseases, Ninth Revision (ICD-9) to identify and report diseases, signs, and symptoms as well as to measure morbidity and mortality in the United States. In general, coders identify ICD-9 as the heartbeat of reimbursement for medical procedures because this is what drives medical necessity.
Never Give Up on a Patient
ACR President David Borenstein, MD, receives AF honor for his dedication to rheumatology
Opioids More Dangerous than other Analgesics for Elderly
Safety events vary among different opioids
Could Lipids Be a Key to Control Inflammation?
Presenters spotlight complex relationship between lipid metabolism, atherosclerosis, and autoimmune disorders
A Catalyst for Antiphospholipid Syndrome Research
APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder
Similarities to Fibromyalgia Found in Post-War Illness
Many questions remain about these chronic multisymptom illnesses
- « Previous Page
- 1
- …
- 73
- 74
- 75
- 76
- 77
- …
- 82
- Next Page »